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Abstract
Introduction
Dengue is the most important mosquito-borne diseases worldwide but was considered
scarce in West-Central Africa. During the last decade, dengue outbreaks have increasingly
been reported in urban foci in this region suggesting major epidemiological changes. How-
ever, in Central Africa where both vectors, Aedes aegypti and Aedes albopictus are well
established, the role of each species in dengue transmission remains poorly investigated.
Methodology/Principal findings
Field-collected strains of Ae. aegypti and Ae. albopictus from different ecological settings in
Central Africa were experimentally challenged with dengue 2 virus (DENV-2). Mosquitoes
were analysed at 14- and 21-days post-infection. Analysis provide evidence that both Ae.
aegypti and Ae. albopictus in Central Africa were able to transmit dengue virus with Ae.
aegypti exhibiting a higher transmission rate. Unexpectedly, two Ae. aegypti populations
from Be´noue´ and Maroua, in northern Cameroon, were not able to transmit DENV-2.
Conclusions/Significance
We conclude that both Ae. aegypti and Ae. albopictus are susceptible to DENV-2 and may
intervene as active dengue vectors. These findings highlight the urgent need to plan a vector
surveillance program and control methods against dengue vectors in Central Africa in order
to prevent future outbreaks.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007985 December 30, 2019 1 / 12
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Kamgang B, Vazeille M, Tedjou AN,
Wilson-Bahun TA, Yougang AP, Mousson L, et al.
(2019) Risk of dengue in Central Africa: Vector
competence studies with Aedes aegypti and Aedes
albopictus (Diptera: Culicidae) populations and
dengue 2 virus. PLoS Negl Trop Dis 13(12):
e0007985. https://doi.org/10.1371/journal.
pntd.0007985
Editor: Duane J. Gubler, Duke-NUS GMS,
SINGAPORE
Received: September 9, 2019
Accepted: December 10, 2019
Published: December 30, 2019
Copyright: © 2019 Kamgang et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript.
Funding: BK was funded by the Wellcome Trust,
204862/Z/16/Z (https://wellcome.ac.uk). The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Author summary
Dengue virus (DENV) is a flavivirus mainly transmitted to humans through the bite of
infected mosquitoes notably Aedes aegypti and Aedes albopictus. In Central Africa
where both vectors, Ae. aegypti and Ae. albopictus are well established, the role of each
species in dengue transmission remains poorly investigated. Here, we assessed the vec-
tor competence of Ae. aegypti and Ae. albopictus collected in different ecological settings
in Central Africa to transmit dengue 2 virus (DENV-2). We provide evidence that both
Ae. aegypti and Ae. albopictus in Central Africa were able to transmit dengue virus with
Ae. aegypti exhibiting a higher transmission rate. These findings could increase the risk
of dengue outbreak in the region and emphasize the need for a comprehensive vector
surveillance program to prevent and preparedness for an intervention in case of
outbreaks.
Introduction
Dengue is one of the most important arboviral diseases in the world with nearly 390 million
annual dengue infections and 96 million (67–136 million) clinical cases [1]. Dengue is caused
by a dengue virus (DENV) belonging to the genus Flavivirus (family Flaviviridae). There are
four distinct, but closely related serotypes of dengue (DENV-1, DENV-2, DENV-3 and
DENV-4). DENV is transmitted to humans through the bite of infected Aedes mosquitoes pri-
marily Aedes aegypti Linneaus 1772 and Aedes albopictus (Skuse 1894).
In Africa, the situation of dengue was less critical as human cases were mainly associated
with mild symptoms [2,3]. Haemorrhagic syndromes were only reported in East Africa [4,5].
However, dengue outbreaks have been reported recently in some West-Central African coun-
tries [6–10] suggesting a switch in the epidemiological dynamics of dengue. The two invasive
species, Ae. aegypti and Ae. albopictus are well established in Africa. While Ae. aegypti native
from Africa took 400–500 years to invade the tropical belt [11,12], Ae. albopictus originated
from Asian forests has colonized all five continents in less than four decades [13,14]. Aedes
albopictus has been first reported in Central Africa in early 2000s in Cameroon [15], and since
then, this species has invaded almost all countries of the region including the Republic of
Congo [16–18]. In sympatric areas, Ae. albopictus outcompetes with the native species Ae.
aegypti [18–21]. Coincidentally, the emergence of arboviral diseases such as dengue and chi-
kungunya in Central Africa has coincided with the establishment of Ae. albopictus in this
region. Indeed, Ae. albopictus was identified as the main vector during concurrent dengue/chi-
kungunya outbreak in Gabon in 2007 [8,22], and in Cameroon in 2006 [23]. During the last
two decades, DENV-1 and DENV-2 mainly, were circulating in Cameroon [24–29]. Nation-
wide surveillance of dengue in 2006/2007 only revealed that seroprevalence (IgG and IgM anti-
bodies) was higher in Douala [29]. In the neighbouring country, the Republic of the Congo,
only little information is known about dengue circulation. The vector competence (which
refers to the potential of an arthropod to ingest the pathogen, ensure replication, dissemination
and transmission) which is one of the main factors required to establish the epidemiological
role of mosquitoes in transmission is poorly studied in Central Africa. Previous studies only
focused on infection and dissemination rates [8,30,31] and not transmission potential (i.e.
virus detection in mosquito saliva). To fill this important gap, we performed a comparative
analysis aiming to assess the ability of Ae. aegypti and Ae. albopictus collected in different eco-
logical settings in Central Africa to transmit DENV-2.
Risk of dengue in Central Africa
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007985 December 30, 2019 2 / 12
Materials and methods
Ethics statement
This study was approved by the Cameroonian national ethics committee for human health
research N˚2017/05/911/CE/CNERSH/SP. Oral consent to inspect the potential breeding sites
was obtained in the field in household or garage owners. The Institut Pasteur animal facility
has received accreditation from the French Ministry of Agriculture to perform experiments on
live animals in compliance with the French and European regulations on care and protection
of laboratory animals (EC Directive 2010/63, French Law 2013–118, February 6th, 2013). All
experiments were approved by the Ethics Committee and registered under the reference APA-
FIS6573-201606l412077987 v2.
Mosquito sampling
Larvae and pupae were collected from August 2017 to April 2018 in several locations in Cen-
tral Africa including Brazzaville (Republic of the Congo), Yaounde´, Douala, Tibati and Be´noue´
National Park (Cameroon, Fig 1). Each of these locations have been previously characterised
[18,19]. In each location, mosquitoes were collected in peri-urban (i.e. peripheral area of the
city) and downtown (i.e. city centre with high building density) from a minimum of 20 con-
tainers per environment. Immature stages of Aedes were transported in the insectary and
pooled together according to the city. Larvae were raised until adults and identified morpho-
logically. Adults from same location and species were reared at 28˚±1˚C under 12h dark:12h
light cycle and 80% relative humidity. Eggs obtained (Table 1) were transported to the Institut
Pasteur Paris, reared to adult stage and used to challenge with DENV-2.
Virus strain
The dengue 2 virus (DENV-2) strain provided by Leon Rosen (Institut Pasteur, Paris, France)
was isolated in 1974 from a human sera from Bangkok, Thailand [32]. This virus had been
passed only in different mosquito species (Toxorhynchites amboinensis, Ae. albopictus, and Ae.
aegypti) by intrathoracic inoculation. Viral stocks were produced by inoculating Ae. albopictus
cells (C6/36 clone) with triturated infected mosquitoes.
Challenging mosquitoes with DENV-2
For each sample, six batches of 60 7–10 day old females were challenged with an infectious
blood meal (Institut Pasteur, Paris, France) containing 1.4 mL of washed rabbit erythrocytes
and 700 μL of viral suspension. The blood meal was supplemented with adenosine 5’-triphos-
phate (ATP) as a phagostimulant at a final concentration of 1 mM and provided to mosquitoes
at a viral titre of 107 focus-forming unit (ffu)/mL using a Hemotek membrane feeding system
(Hemotek Ltd, Blackburn, United Kingdom). Mosquitoes were allowed to feed for 20 min
through a piece of pork intestine (Institut Pasteur, Paris, France) covering the base of a Hemo-
tek feeder maintained at 37˚C. Fully engorged females were transferred in cardboard contain-
ers and maintained with 10% sucrose under controlled conditions (28±1˚C, relative humidity
of 80%, light: dark cycle of 12 h: 12 h) for up to 21 days with mosquito analysis 14 and 21 days
post-infection (dpi). 21–32 mosquitoes were examined at each dpi.
Infection, dissemination and transmission assays
For each mosquito examined, body (abdomen and thorax) and head were tested respectively
for infection and dissemination rates at 14 and 21 dpi. For this, each part was ground individu-
ally in 300 μL of L15 medium (Invitrogen, CA, USA) supplemented with 2% fetal serum
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bovine (FBS), and centrifuged at 10,000×g for 5 min at +4˚C. The supernatant was processed
for viral titration. Saliva was collected from individual mosquitoes using technique of forced
salivation as described previously [33]. Briefly, mosquitoes were cool anesthetized, wings and
legs of each mosquito were removed and the proboscis inserted into a tip of 20 μL containing
5 μL of FBS. After 30 min, FBS containing saliva was mixed in 45 μL of L15 medium for
titration.
Fig 1. Map of Cameroon vegetation showing the sampling sites.
https://doi.org/10.1371/journal.pntd.0007985.g001
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Infection rate (IR) refers to the proportion of mosquitoes with infected body (i.e. abdomen
and thorax) among tested mosquitoes. Disseminated infection rate (DIR) corresponds to the
proportion of mosquitoes with infected head among the previously detected infected mosqui-
toes (i.e. virus positive abdomen/thorax). Transmission rate (TR) represents the proportion of
mosquitoes with infectious saliva among mosquitoes with disseminated infection. Vector com-
petence can be summarized by the transmission efficiency (TE) which was calculated as the
proportion of mosquitoes with infectious saliva among total of mosquitoes tested [34].
Viral titration by focus forming assay
Samples were titrated by focus fluorescent assay on Ae. albopictus C6/36 cells [35]. Body, head
and saliva suspensions were serially diluted in L15 medium supplemented with 2% of FBS and
inoculated onto cells in 96-well plates. After incubation of 5 days at 28˚C, samples were fixed
with 0.1mL/well of formaldehyde 3.6% in phosphate buffer saline (PBS) during 20 min at
room temperature. Then, plates were stained using antibodies specific to DENV as the primary
antibody, and conjugated goat anti-mouse immunoglobulin G (Alexa Fluor 488) as the second
antibody (Life Technologies, CA, USA). Titres were expressed as ffu/mL.
Statistical analysis
All statistical analyses were performed with R software v 3.5.2 (R Core Team, Vienna, Austria).
Qualitative variables were expressed as proportion and compared using Fisher’s exact test
(RVAideMemoire package). While quantitative variables were described as mean and com-
pared using non-parametric test of Kruskal-Wallis because of non-normal distribution. Pair-
wise comparison were performed using Fisher’s exact test for proportions and Kruskal-wallis
test for means. P-value<0.05 was considered as statistically different.
Results
Infection and disseminated infection rates in Ae. albopictus and Ae. aegypti
To determine if Ae. aegypti (six populations) or Ae. albopictus (four populations) were more
likely to sustain DENV outbreak in Central Africa, the ability of the virus to replicate and dis-
seminate in both species was examined at 14 and 21 dpi as well as DENV particles excreted in
saliva (only at 21 dpi) (Figs 2 and 3). At 14 dpi, Ae. albopictus infection rate (IR) ranged from
33.3% in Douala population to 68.4% in Yaounde´ urban population but no statistical differ-
ence was detected (Fig 2A, Fisher’s Exact test: P = 0.16). For DIRs, similar trend was observed
with lowest rate in Douala population (14.3%) and highest in Brazzaville population (41.6%)
Table 1. Origin of Ae. aegypti and Ae. albopictus used for vector competence.
Location Species Generation
Yaounde´ urban Ae. albopictus G2
Tibati Ae. albopictus G2
Douala Ae. albopictus G2
Brazzaville Ae. albopictus G5
Yaounde´ urban Ae. aegypti G2
Yaounde´ rural Ae. aegypti G2
Be´noue´ Parc Ae. aegypti G4
Brazzaville Ae. aegypti G2
Maroua Ae. aegypti G2
Douala Ae. aegypti G2
https://doi.org/10.1371/journal.pntd.0007985.t001
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(Fig 2A, Fisher’s Exact test: P = 0.47). While for Ae. aegypti, results exhibited higher IRs rang-
ing from 70.83% for Maroua to 100% for Douala populations and DIRs varying from 58.82%
for Maroua to 100% for Douala populations. When considering all populations of same spe-
cies, IRs for Ae. aegypti (mean = 76.61%) was significantly higher than for Ae. albopictus
(mean = 51.76%) (Fisher’s exact test: P = 0.0003). Similar pattern was found for DIRs (Ae.
aegypti: mean = 83.15% and Ae. albopictus: mean = 27.27%) (Fig 3A, Fisher’s exact test:
P<10−6).
At 21 dpi, Ae. albopictus displayed higher IRs ranging from 50% for Douala population to
83.3% for Yaounde´ urban and were not significantly different (Fisher exact test: P = 0.06). But
pairwise comparisons showed that significant difference was found between Douala and
Yaounde´ urban (Fisher’s exact test: P = 0.03), Tibati and Yaounde´ urban (Fisher’s exact test:
Fig 2. Infection, disseminated infection, transmission rates and transmission efficiency of Ae. albopictus from Central Africa to dengue
virus. A) Infection and disseminated infection rates at 14 days post-infection (dpi). B) Infection, disseminated infection, transmission rates and
transmission efficiency at 21 dpi. Error bars show the 95% confidence interval. In brackets, the number of mosquitoes examined. IR: the
proportion of mosquitoes with infected body among engorged mosquitoes; DIR: the proportion of mosquitoes with infected head among
mosquitoes with infected body; TR: the proportion of mosquitoes with infectious saliva among mosquitoes with infected head. TE: the
proportion of mosquitoes with infectious saliva among all analysed ones.
https://doi.org/10.1371/journal.pntd.0007985.g002
Fig 3. Infection, disseminated infection, transmission rates and transmission efficiency of Ae. aegypti from Central Africa to dengue virus.
A) Infection and disseminated infection rates at 14 days post-infection (dpi). B) Infection, disseminated infection, transmission rates and
transmission efficiency at 21 dpi. Error bars show the 95% confidence interval. In brackets, the number of mosquitoes examined. IR: the
proportion of mosquitoes with infected body among engorged mosquitoes; DIR: the proportion of mosquitoes with infected head among
mosquitoes with infected body; TR: the proportion of mosquitoes with infectious saliva among mosquitoes with infected head. TE: the
proportion of mosquitoes with infectious saliva among all analysed ones.
https://doi.org/10.1371/journal.pntd.0007985.g003
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P = 0.03). Higher DIRs was also reported: it varied from 70% for Yaounde´ urban population to
91.66% for Douala population but no significant difference was found according to population
(Fisher’s exact test: P = 0.52). For Ae. aegypti, IRs ranged from 70.83% for Be´noue´ population
to 95.83% for Brazzaville and Douala populations and were not statistically different (Fisher
exact test: P = 0.06). In contrast, a higher significant variation of DIRs was reported: it ranged
from 41.17% for Be´noue´ population to 95.65% for Brazzaville population (Fisher exact test:
P<10−6). Overall, IRs for Ae. aegypti (mean = 81.94%) were significantly higher than for Ae.
albopictus (mean = 61.05%) (Fisher exact test: P = 0.0005). For DIR, no significant difference
was found between Ae. aegypti and Ae. albopictus population (Fisher exact test: P = 0.45).
Transmission rate and efficiency
Transmission rate (TR) and Transmission efficiency (TE) were assessed at 21 dpi in four Ae.
albopictus and six Ae. aegypti populations (Figs 2B and 3B). In Ae. albopictus, DENV was
detected in saliva of four populations with TRs ranging from 9.1% (1/11) for Douala to 50%
(5/10) for Tibati populations; TRs were not statistically different (Fig 2B, Fisher exact test:
P = 0.2). In contrast, for Ae. aegypti, DENV was not detected in saliva of Maroua and Be´noue´
populations, both located in northern Cameroon suggesting a low vector competence of these
populations. For the other Ae. aegypti populations, TR ranged from 21.42% for Yaounde´
urban population to 50% for Douala population (Fig 3B, Fisher exact test: P = 0.4). Overall, no
significant difference was reported among Ae. aegypti and Ae. albopictus regarding TRs and
TEs (Fisher exact test: P>0.05). When comparing populations from sympatric areas, TRs were
significantly higher for Ae. aegypti (mean = 50%) than for Ae. albopictus (mean = 27.7%)
(Fisher exact test: P = 0.007) while for viral load, no significant difference was reported
between both species (Chi-squared = 0.14, df = 1, P = 0.70). For Ae. aegypti, no significant vari-
ation of viral loads was reported according to population (Fig 4; Chi-squared = 0.29, df = 3,
Fig 4. Dengue virus titres in saliva of Ae. aegypti and Ae. albopictus at 21 days post-infection. The bars indicate the confidence interval of the
mean for viral load in each population.
https://doi.org/10.1371/journal.pntd.0007985.g004
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P = 0.96) while for Ae. albopictus, a significant difference of viral loads was detected between
Tibati and Brazzaville samples (Fig 4; Chi-squared = 2.31, df = 1, P = 0.018).
Discussion
During the past decade, there has been a rise of dengue cases in urban foci in Central Africa
notably in Cameroon [26–29]. Even suspected, vectors were not well identified and character-
ised. In this study, we assessed for the first time, the ability of Ae. aegypti and Ae. albopictus
collected in different ecological settings (Fig 1) in Central Africa to transmit DENV-2, a sero-
type repeatedly reported in the region [9,29]. We demonstrated that DENV-2 was able to repli-
cate, disseminate and be secreted in saliva of both Ae. aegypti and Ae. albopictus populations
from Central Africa, thus enable to transmit DENV. However, infection rates were signifi-
cantly higher for Ae. aegypti than for Ae. albopictus at 14 and 21 dpi. Disseminated infection
rates followed the same trend at 14 dpi. Nevertheless, DENV was detected in saliva of all Ae.
albopictus populations tested while for Ae. aegypti, virus was not detected in both populations
(2/6) from northern Cameroon, Be´noue´ and Maroua. These results suggest that vector compe-
tence of Ae. aegypti to DENV-2 in Central Africa vary significantly according to geographical
population as previously suggested elsewhere [36,37]. This may due to the fact that populations
from Be´noue´ and Maroua exhibited an extrinsic incubation period longer than 21 days; to
note, the extrinsic incubation period refers to the duration between the ingestion of an infec-
tious blood meal and the excretion of virus in saliva when the mosquito bites [38]. It depends
on the three-way combination of mosquito, virus and environment described under genotype-
by-genotype-by-environment (GxGxE) interactions [39]. In addition, low vector competence
in these populations would be due to presence of specific refractory genes [40,41]. Indeed,
refractoriness of mosquito to dengue virus may be caused by different parameters like micro-
biome composition as bacterial symbionts of mosquitoes have been shown to alter the vector
competence to arboviruses [42] and immune system of mosquito since it was demonstrated
that anti-viral immunity in mosquito vectors is critical to prevent virus replication and trans-
mission [43]. Further investigations in this regard are needed to elucidate.
Moreover, the seroprevalence of dengue examined in 2006/2007 in three main cities of
Cameroon located in different ecological settings revealed that anti-DENV IgG and IgM anti-
bodies varied significantly with a higher prevalence reported in Douala [29], location where
the highest transmission rate and viral load were also detected in Ae. aegypti in this study.
Beside the mosquito genetic background, mosquito microbiome can modulate arbovirus
transmission [42,44,45]. The transmission rate was higher for Ae. aegypti compared to Ae.
albopictus in locations where both species are sympatric. This result is in agreement with the
fact that Ae. aegypti is considered as a major dengue vector, and Ae. albopictus, the secondary
one [46]. Meanwhile, it would be interesting to highlight that Ae. albopictus can become a
major dengue vector in the absence of Ae. aegypti as reported previously in China, the Sey-
chelles, Japan, Hawaii and on La Re´union [47] or when Ae. albopictus becomes the most preva-
lent species as reported in Gabon [8]. Nevertheless, infection and disseminated infection rates
assessed for Ae. albopictus in this study are similar to those reported in previous studies in
Africa [8,31] and in Southeast Asia [48]. For Ae. aegypti, infection and disseminated infection
rates are higher compared to that previously reported in Cameroon (17.2% to 59.7%) but simi-
lar to that often reported outside Africa [37,48]. Albeit Ae. aegypti is more competent than Ae.
albopictus to transmit DENV, some parameters can influence DENV transmission in nature,
such as vector densities, host preference, virus evolution and proportion of immunologically
naive people [49]. Additional studies using a local strain of DENV circulating in Central Africa
are needed to validate these results. Regarding vector densities, recent studies in Cameroon
Risk of dengue in Central Africa
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and Republic of Congo revealed that Ae. albopictus tends to replace Ae. aegypti in most areas
where both species are sympatric [18,19]. It was also demonstrated that in Yaounde´ (Camer-
oon) Ae. albopictus preferentially fed on humans rather than on available domestic animals
[50] Data generated in our study demonstrated that both Ae. aegypti and Ae. albopictus can
sustain dengue transmission in Central Africa. This could increase the risk of dengue outbreak
in the region and urge the need of a vector surveillance program to prevent and preparedness
for an intervention in case of outbreaks.
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